Kumar SK, Buadi FK, LaPlant B, et al. Phase 1/2 trial of ixazomib, cyclophosphamide, dexamethasone in patients with previously untreated symptomatic multiple myeloma. Blood Cancer J. 2018, 8(8):70. doi: 10.1038/s41408-018-0106-3.
Advertisement
Articles by Kumar SK, Buadi FK, LaPlant B, et al. Phase 1/2 trial of ixazomib, cyclophosphamide, dexamethasone in patients with previously untreated symptomatic multiple myeloma. Blood Cancer J. 2018, 8(8):70. doi: 10.1038/s41408-018-0106-3.
Advertisement
Latest Updated Articles
- Study Summary: Ixazomib, Cyclophosphamide, and Dexamethasone for Previously Untreated Symptomatic Multiple Myeloma
Published: October 24th 2018 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
CDC Reduces US Childhood Immunization Schedule From 17 to 11 Diseases
2
GLP-1s More Effective at Preventing Colorectal Cancer Than Aspirin
3
Nimbus Therapeutics, Eli Lilly Partner to Develop Novel Oral Metabolic Drug
4
Telemedicine Utilization and Preventive Services Among a Rural Population
5
